PD-L1 Expression in Lung Adenocarcinomas Correlates with KRAS Mutations and Th1/Cytotoxic T Lymphocyte Microenvironment

被引：0
|
作者：
Huynh, Tiffany [1 ]
Morales-Oyarvide, Vicente [2 ]
Uruga, Hironori [1 ]
Bozkurtlar, Emine [1 ]
Gainor, Justin F. [3 ]
Hata, Aaron [3 ]
Mark, Eugene [1 ]
Lanuti, Michael [4 ]
Engelman, Jeffrey A. [5 ]
Mino-Kenudson, Mari [1 ]
机构：
[1] Massachusetts Gen Hosp, Pathol, Boston, MA 02114 USA
[2] Harvard Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Boston, MA 02115 USA
[3] Massachusetts Gen Hosp, Canc Ctr, Boston, MA 02114 USA
[4] Massachusetts Gen Hosp, Thorac Surg, Boston, MA 02114 USA
[5] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期
关键词：
Immunotherapy; Tumor biology; lung cancer;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ORAL13.01
引用
收藏
页码：S198 / S198
页数：1
相关论文
共 50 条
  • [11] PD-L1 expression and PD-1/PD-L1 inhibitors in breast cancer
    Monneur, Audrey
    Goncalves, Anthony
    Bertucci, Francois
    BULLETIN DU CANCER, 2018, 105 (03) : 261 - 272
  • [12] PD-L1 Expression in Systemic Immune Cell Populations as a Potential Predictive Biomarker of Responses to PD-L1/PD-1 Blockade Therapy in Lung Cancer
    Bocanegra, Ana
    Fernandez-Hinojal, Gonzalo
    Zuazo-Ibarra, Miren
    Arasanz, Hugo
    Jesus Garcia-Granda, Maria
    Hernandez, Carlos
    Ibanez, Maria
    Hernandez-Marin, Berta
    Martinez-Aguillo, Maite
    Jose Lecumberri, Maria
    Fernandez de Lascoiti, Angela
    Teijeira, Lucia
    Morilla, Idoia
    Vera, Ruth
    Escors, David
    Kochan, Grazyna
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (07):
  • [13] Computational Biological Model Prediction of PD-L1 Expression and Immunotherapy Response for KRAS Mutated Lung Cancer Based on Co-Mutations
    Padda, S.
    Aredo, J.
    Vali, S.
    Singh, N.
    Vasista, S.
    Mitra, U.
    Abbasi, T.
    Wakelee, H.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S533 - S533
  • [14] Comparative expression analysis of PD-1, PD-L1, and CD8A in lung adenocarcinoma
    Ma, Ke
    Qiao, Yulei
    Wang, Hao
    Wang, Shuai
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (22)
  • [15] Evaluation on the Distribution of EGFR, KRAS and BRAF Genes and the Expression of PD-L1 in Different Types of Lung Cancer
    Zhao, Rui
    Gao, Shan
    He, Haiqi
    Zhang, Jia
    Zhang, Guangjian
    Wen, Xiaopeng
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2021, 14 : 5615 - 5620
  • [16] Expression of PD-L1 correlates with pleomorphic morphology and histological patterns of non-small-cell lung carcinomas
    Kwong, Francois Ng Kee
    Laggner, Ute
    McKinney, Olivia
    Croud, James
    Rice, Alexandra
    Nicholson, Andrew G.
    HISTOPATHOLOGY, 2018, 72 (06) : 1024 - 1032
  • [17] Regulation of PD-L1 expression by matrix stiffness in lung cancer cells
    Miyazawa, Ayako
    Ito, Satoru
    Asano, Shuichi
    Tanaka, Ichidai
    Sato, Mitsuo
    Kondo, Masashi
    Hasegawa, Yoshinori
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 495 (03) : 2344 - 2349
  • [18] Tumor-derived exosomal PD-L1: a new perspective in PD-1/PD-L1 therapy for lung cancer
    Wu, Yunjiao
    Fu, Huichao
    Hao, Jingwei
    Yang, Zhaoyang
    Qiao, Xinyi
    Li, Yingjie
    Zhao, Rui
    Lin, Tie
    Wang, Yicun
    Wang, Meng
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [19] PD-L1 Expression in Early Stage Lung Cancer
    Chung, J.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1710 - S1710
  • [20] The landscape of PD-L1 expression and somatic mutations in hepatocellular carcinoma
    Xu, Hao
    Liang, Xiao-Lu
    Liu, Xiao-Guang
    Chen, Nian-Ping
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2021, 12 (03) : 1132 - +
12345